US seed company Monsanto Co turned down a sweetened $64 billion acquisition offer from Bayer AG, but said it was open to further talks with the German healthcare and chemicals group as well as other parties.
The widely expected re
Bayer AG, the German chemicals and healthcare company trying to acquire Monsanto, is exploring a sale of its radiology supplies unit that could be worth more than $3 billion, according to people familiar with the matter.
German drugs and crop chemicals group Bayer has offered to buy US seeds company Monsanto for $62 billion in cash, defying criticism from some of its own shareholders in a bid to grab the top spot in a fast-consolidating farm supplies industry.
Latest developments and trends in different medical fields were discussed by over 350 physicians at a number of conferences in Dubai this month. The events were organised by pharma giant Bayer, as part of its Bayer Day.
Bayer Middle East recently organized a regional training workshop for 200 pharmacists from 11 countries to equip them with the necessary skill sets required to work with patients.
The workshop is part of Bayer Prestige Club’
Honeywell, a technology and manufacturing leader, has joined hands with Bayer Pearl, a polyurethane systems house, to introduce a new spray foam system in the Middle East region.
A joint venture between Bayer MaterialScience AG an
More than 200 pharmacists and industry experts came together in Dubai, UAE, for a regional training programme that equipped them with the necessary skill sets required to work with patients.
In the constantly evolving healthcare s
Merck & Co Inc has agreed to sell its consumer care business to Germany's Bayer AG for $14.2 billion, the companies said on Tuesday, adding to a string of major cross-border healthcare deals.
"This acquisition marks a
Bayer MaterialScience, a leading manufacturer of high-tech polymer materials, has inaugurated its new coatings, adhesives and specialties laboratory at DuBiotech premises in Dubai.
This application and development lab will offer l
India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, in a major blow to global pharmaceutical firms, experts say.
On Monday, the Indian Patent Offi